EUVIMEDEUVIMED entdecken
Crossref

Breast Explantation With Simultaneous Mastopexy and Volume Restoration: An Analysis of Clinical Outcomes and Prospective Quality of Life

Charles A Messa iD, Charles A Messa

Aesthetic Surgery Journal · 15.07.2023 · 43 (8) · 840-852

DOI: 10.1093/asj/sjad062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 13.03.2023. Verfasst von Charles A Messa und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mammaplasty, Breast Implants, Breast Implantation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An increasing number of patients are undergoing explantation to alleviate symptoms attributed to the presence of a prothesis or dissatisfaction with the appearance of their breasts.

Objectives

The authors aim to evaluate the clinical effectiveness and quality of life (QoL) of simultaneous explantation, capsulectomy, and mastopexy for patients requesting implant removal.

Methods

Two hundred sixty-two simultaneous explantation, capsulectomy, and mastopexy (ECM) procedures were performed in 131 patients from 2009 to 2019. Prospective QoL assessment was administered for all patients. Inclusion criteria included a minimum postoperative follow-up of 6 months and completion of a practice-generated patient reported outcomes (PRO) questionnaire. Wilcoxon signed-rank test was performed to compare changes in QoL scores.

Results

Mean follow-up and BMI were 23 months (6 months to 8 years) and 24.8 kg/m2 (18–34 kg/m2), respectively. Mean age was 48.3 years (26–75 years). Autologous fat grafting was performed simultaneously in patients 47.3% (n = 62). The complication rate was 3.8% (n = 10 breasts) in 9 patients (6.9%). The overall reoperation rate was 7.3% of procedures (n = 19 breasts) and 9.2% of patients (n = 12), including secondary autologous fat grafting (11.3%, n = 7). PRO results demonstrated a significant improvement in all QoL domains, including physical well-being (P < .005), psychological well-being (P < .005), sexual well-being (P < .005), breast shape (P < .005), and breast appearance (P < .005). With respect to breast implant illness symptoms, 59 patients (88.1%) noted reduced pain, myalgias/arthralgias, and fatigue after ECM.

Conclusions

This study presents an effective paradigm to manage implant removal through simultaneous explantation, capsulectomy, and mastopexy with acceptable clinical outcomes and a significant improvement in QoL and breast aesthetics. Level of Evidence: 4

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MammaplastyBreast ImplantsBreast ImplantationHumansMiddle AgedQuality of LifeProspective StudiesFollow-Up StudiesRetrospective StudiesTreatment Outcome

Autor:innen und Institutionen

ORCID-Profile: Charles A Messa

Zitieren

APA

Messa, C. A., & Messa, C. A. (2023). Breast Explantation With Simultaneous Mastopexy and Volume Restoration: An Analysis of Clinical Outcomes and Prospective Quality of Life. Aesthetic Surgery Journal, 43(8), 840-852. https://doi.org/10.1093/asj/sjad062

Vancouver

Messa CA, Messa CA. Breast Explantation With Simultaneous Mastopexy and Volume Restoration: An Analysis of Clinical Outcomes and Prospective Quality of Life. Aesthetic Surgery Journal. 2023;43(8):840-852. doi:10.1093/asj/sjad062

BibTeX
@article{Messa2023,
  author = {Messa, Charles A and Messa, Charles A},
  title = {Breast Explantation With Simultaneous Mastopexy and Volume Restoration: An Analysis of Clinical Outcomes and Prospective Quality of Life},
  journal = {Aesthetic Surgery Journal},
  year = {2023},
  volume = {43},
  number = {8},
  pages = {840--852},
  doi = {10.1093/asj/sjad062}
}
Kostenlos starten →